Prognostic Significance of CREB-Binding Protein and CD81 Expression in Primary High Grade Non-Muscle Invasive Bladder Cancer: Identification of Novel Biomarkers for Bladder Cancer Using Antibody Microarray.
High-grade (HG) bladder cancers (BCs) are genetically unstable and have an unpredictable course. The identification of prognostic factors in HG non-muscle invasive BC (NMIBC) is crucial for improving patients' quality of life and preventing BC-specific mortality. Here, we used an antibody microarray (AbM) to identify novel candidate biomarkers in primary HG NMIBC and validated the prognostic significance of the candidate biomarkers. Three pairs of tissue samples from primary HG NMIBC and normal urothelium were analyzed using an AbM kit containing 656 antibodies, and differentially expressed proteins were identified. Among the 42 upregulated and 14 downregulated proteins with statistical significance in BC tissues, CREB-binding protein and CD81 were selected as representative upregulated and downregulated candidate biomarkers, respectively. We then validated the expression of these candidate biomarkers in primary human urothelial cells and BC cell lines by western blotting and immunofluorescence assays, and the results were consistent with the AbM expression profiles. Additionally, Kaplan-Meier survival using immunohistochemical data from an independent primary HG NMIBC cohort comprising 113 patients showed that expression of the 2 biomarkers was significantly associated with recurrence-free and progression-free survival. In multivariate analysis, the 2 biomarkers remained significant predictors for recurrence-free survival. Taken together, our findings suggest that expression of CREB-binding protein and CD81 in BC tissue specimens may have prognostic value in patients with primary HG NMIBC.
Department of Microbiology, Eulji University School of Medicine, Daejeon, South Korea.
Myung-Shin
MS
Lee
Department of Pathology, Eulji University School of Medicine, Daejeon, South Korea.
Joo Heon
JH
Kim
Department of Microbiology, Eulji University School of Medicine, Daejeon, South Korea.
Ji-Su
JS
Lee
Department of Urology, College of Medicine, Chungbuk National University, Cheongju, South Korea.
Seok Joong
SJ
Yun
Department of Urology, College of Medicine, Chungbuk National University, Cheongju, South Korea.
Wun-Jae
WJ
Kim
Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Hanjong
H
Ahn
Department of Urology, Eulji University Hospital, Eulji University School of Medicine, Daejeon, South Korea.
Jinsung
J
Park
D015415:Biomarkers / Q000378:metabolism; D050882:CREB-Binding Protein / Q000378:metabolism*; D002478:Cells, Cultured; D018450:Disease Progression; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D053208:Kaplan-Meier Estimate; D008297:Male; D046228:Microarray Analysis / Q000379:methods; D009361:Neoplasm Invasiveness / Q000473:pathology; D011379:Prognosis; D060225:Tetraspanin 28 / Q000378:metabolism*; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis* / Q000378:metabolism / Q000473:pathology
D015415:Biomarkers; C554798:CD81 protein, human; D060225:Tetraspanin 28; D050882:CREB-Binding Protein